Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Intact Vascular

Intact Vascular
2011 FOUNDED
PRIVATE STATUS
31-40 EMPLOYEES
Series C LATEST DEAL TYPE
$25M LATEST DEAL AMOUNT
4 INVESTORS
Description

Developer of medical devices created to be used for minimally invasive peripheral vascular procedures. The company's products are designed to optimize peripheral balloon angioplasty results in the treatment of peripheral artery disease, offering physicians a new treatment that is safe, efficacious and easy to use.

Formerly Known As
Tackit Vascular
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Surgical Devices
Primary Office
  • 1285 Drummers Lane
  • Suite 200
  • Wayne, PA 19087
  • United States

+1 (484) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Intact Vascular’s full profile, request a free trial.

Intact Vascular Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series C) 24-May-2019 $25M 00000 00000 Completed Generating Revenue
4. Later Stage VC (Series C) 16-Apr-2018 0000 000.00 00000 Completed Generating Revenue
3. Later Stage VC (Series B) 03-Jan-2017 0000 000.00 0000 Completed Startup
2. Early Stage VC (Series A2) 20-Dec-2013 $4.69M $20.2M 000.00 Completed Startup
1. Early Stage VC (Series A2) 30-Aug-2012 $15.5M $15.5M 000.00 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Intact Vascular Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series C 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series B1 0,000,000 00.000000 00 00.00 00.00 00 00.00 0.000
Series B 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.00
Series A2 18,171,588 $0.001000 8% $0.92 $0.92 1x $0.92 11.9%
Series A1 4,050,000 $0.001000 8% $0.25
To view this company’s complete Cap Table, request access »

Intact Vascular Competitors (17)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Inari Medical Venture Capital-Backed Irvine, CA 00 000.00 00000000000 000.00
000000000000 Formerly VC-backed Morrisville, NC 000 00000 00000000000 00000
00 000000 Venture Capital-Backed Milpitas, CA 00 00000 0000000000 0 00000
00000000 Venture Capital-Backed Herzlia, Israel 00 0000 000000&0 0000
00000000 0000000 Venture Capital-Backed Mountain View, CA 00 000.00 000000000 000.00
To view this company’s complete list of competitors, request access »

Intact Vascular Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Vensana Capital Venture Capital Minority 000 0000 000000 0
New Enterprise Associates Venture Capital Minority 000 0000 000000 0
H.I.G. BioHealth Partners Venture Capital Minority 000 0000 000000 0
Quaker Partners Venture Capital Minority 000 0000 000000 0

Intact Vascular Executive Team (15)

Name Title Board
Seat
Contact
Info
Jim Harrison Director, Implant Research & Development
Peter Schneider MD Co-Founder, Chief Medical Officer & Board Member
Marc Penna Vice President of Clinical Affairs
Howard Rosen Vice President of Marketing & Business Development
Joseph Griffin III Vice President of Regulatory Affairs & Quality Assurance and Compliance Officer

7 Former Executives

You’re viewing 5 of 15 executives. Get the full list »

Intact Vascular Board Members (10)

Name Representing Role Since Contact
Info
Bruce Robertson Ph.D H.I.G. BioHealth Partners Board Member 000 0000
Dennis Wahr MD Self Chairman 000 0000
Douglas Evans Self Board Member 000 0000
Joshua Makower MD Self Board Member 000 0000
Justin Klein MD New Enterprise Associates Board Member 000 0000

3 Former Board Members

You’re viewing 5 of 10 board members. Get the full list »